Seeking Clues to Ecolab (ECL) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

24.10.24 15:15 Uhr

Werte in diesem Artikel
Aktien

233,30 EUR 0,50 EUR 0,21%

Indizes

5.908,6 PKT 15,0 PKT 0,25%

Wall Street analysts forecast that Ecolab (ECL) will report quarterly earnings of $1.82 per share in its upcoming release, pointing to a year-over-year increase of 18.2%. It is anticipated that revenues will amount to $4.02 billion, exhibiting an increase of 1.7% compared to the year-ago quarter.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.That said, let's delve into the average estimates of some Ecolab metrics that Wall Street analysts commonly model and monitor.The combined assessment of analysts suggests that 'Sales- Global Healthcare and Life Sciences (Fixed currency)' will likely reach $330.73 million. The estimate suggests a change of -17.5% year over year.Analysts expect 'Sales- Global Industrial (Public Currency rates)' to come in at $2.00 billion. The estimate indicates a change of +8.5% from the prior-year quarter.Based on the collective assessment of analysts, 'Sales- Global Institutional & Specialty (Fixed currency)' should arrive at $1.40 billion. The estimate suggests a change of +6.9% year over year.It is projected by analysts that the 'Sales- Global Institutional & Specialty (Public Currency rates)' will reach $1.39 billion. The estimate indicates a change of +5.8% from the prior-year quarter.The consensus estimate for 'Sales- Global Industrial (Fixed currency)' stands at $2.00 billion. The estimate indicates a year-over-year change of +9.6%.The average prediction of analysts places 'Sales- Global Healthcare & Life Sciences (Public Currency rates)' at $363.51 million. The estimate indicates a year-over-year change of -10.5%.According to the collective judgment of analysts, 'Operating Income- Global Healthcare and Life Sciences (Fixed currency)' should come in at $27.11 million. Compared to the current estimate, the company reported $44 million in the same quarter of the previous year.Analysts predict that the 'Operating Income- Global Institutional & Specialty (Public Currency rates)' will reach $324.72 million. The estimate is in contrast to the year-ago figure of $250.80 million.Analysts forecast 'Operating Income- Global Industrial (Public Currency rates)' to reach $332.85 million. Compared to the current estimate, the company reported $289.80 million in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'Operating Income- Global Industrial (Fixed currency)' of $331.73 million. The estimate compares to the year-ago value of $287.50 million.The consensus among analysts is that 'Operating Income- Global Institutional & Specialty (Fixed currency)' will reach $331.05 million. The estimate is in contrast to the year-ago figure of $249.90 million.Analysts' assessment points toward 'Operating Income- Global Healthcare & Life Sciences (Public Currency rates)' reaching $41.56 million. Compared to the present estimate, the company reported $45.20 million in the same quarter last year.View all Key Company Metrics for Ecolab here>>>Shares of Ecolab have demonstrated returns of +1.5% over the past month compared to the Zacks S&P 500 composite's +1.5% change. With a Zacks Rank #3 (Hold), ECL is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Ecolab

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ecolab

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ecolab Inc.

Analysen zu Ecolab Inc.

DatumRatingAnalyst
29.03.2018Ecolab OutperformBMO Capital Markets
24.01.2018Ecolab HoldStifel, Nicolaus & Co., Inc.
07.11.2017Ecolab OutperformRBC Capital Markets
12.09.2017Ecolab OutperformRBC Capital Markets
02.08.2017Ecolab BuyUBS AG
DatumRatingAnalyst
29.03.2018Ecolab OutperformBMO Capital Markets
24.01.2018Ecolab HoldStifel, Nicolaus & Co., Inc.
07.11.2017Ecolab OutperformRBC Capital Markets
12.09.2017Ecolab OutperformRBC Capital Markets
02.08.2017Ecolab BuyUBS AG
DatumRatingAnalyst
03.04.2017Ecolab NeutralInstinet
19.10.2015Ecolab HoldDeutsche Bank AG
04.06.2015Ecolab NeutralGlobal Hunter Securities
17.10.2011Ecolab neutralCitigroup Corp.
29.07.2009Ecolab neutralJP Morgan Chase & Co.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ecolab Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"